These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Identification of the ischemic origin of dilated myocardiopathy using positron emission tomography]. Ruiz Salmerón RJ; Jurado López JA; San Martín Gómez MA; Pérez-Castejón MJ; Díaz-Buschmann I; Parra Jiménez FJ; García de la Villa B; Pérez Blasco P; Pasalodos Pita J; Carreras Delgado JL; Medina Peralta J; García García A; Mateos García M Rev Esp Cardiol; 1998; 51 Suppl 1():67-76. PubMed ID: 9549401 [TBL] [Abstract][Full Text] [Related]
5. Metabolic imaging of patients with cardiomyopathy. Geltman EM Circulation; 1991 Sep; 84(3 Suppl):I265-72. PubMed ID: 1884495 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy. Budoff MJ; Shavelle DM; Lamont DH; Kim HT; Akinwale P; Kennedy JM; Brundage BH J Am Coll Cardiol; 1998 Nov; 32(5):1173-8. PubMed ID: 9809922 [TBL] [Abstract][Full Text] [Related]
7. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Danias PG; Ahlberg AW; Clark BA; Messineo F; Levine MG; McGill CC; Mann A; Clive J; Dougherty JE; Waters DD; Heller GV Am J Cardiol; 1998 Nov; 82(10):1253-8. PubMed ID: 9832104 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy. Boff GM; Zanco P; Della Valentina P; Cardaioli P; Thiene G; Chioin R; Dalla Volta S Int J Cardiol; 2000 Jun; 74(1):67-74; discussion 75-6. PubMed ID: 10854681 [TBL] [Abstract][Full Text] [Related]
9. Distinguishing ischemic cardiomyopathy from nonischemic dilated cardiomyopathy with coronary echocardiography. Sawada SG; Ryan T; Segar D; Atherton L; Fineberg N; Davis C; Feigenbaum H J Am Coll Cardiol; 1992 May; 19(6):1223-8. PubMed ID: 1564223 [TBL] [Abstract][Full Text] [Related]
10. Characterization of nontransmural myocardial infarction by positron-emission tomography. Geltman EM; Biello D; Welch MJ; Ter-Pogossian MM; Roberts R; Sobel BE Circulation; 1982 Apr; 65(4):747-55. PubMed ID: 6977420 [TBL] [Abstract][Full Text] [Related]
11. Detection of remote myocardial infarction in patients with positron emission transaxial tomography and intravenous 11C-palmitate. Sobel BE; Weiss ES; Welch MJ; Siegel BA; Ter-Pogossian MM Circulation; 1977 Jun; 55(6):853-7. PubMed ID: 870242 [TBL] [Abstract][Full Text] [Related]
12. Assessment of myocardial fatty acid metabolism with 1-11C-palmitate. Geltman EM J Nucl Cardiol; 1994; 1(2 Pt 2):S15-22. PubMed ID: 9420693 [TBL] [Abstract][Full Text] [Related]
13. Myocardial ischemia and clinical applications of positron emission tomography. Schelbert HR Am J Cardiol; 1989 Sep; 64(9):46E-53E. PubMed ID: 2672767 [TBL] [Abstract][Full Text] [Related]
14. Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. Glamann DB; Lange RA; Corbett JR; Hillis LD Arch Intern Med; 1992 Apr; 152(4):769-72. PubMed ID: 1558434 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy. Bach DS; Beanlands RS; Schwaiger M; Armstrong WF J Am Coll Cardiol; 1995 May; 25(6):1258-62. PubMed ID: 7722118 [TBL] [Abstract][Full Text] [Related]
16. [Usefulness of 123I-BMIPP scanning for distinction of ischemic from nonischemic dilated cardiomyopathy]. Hirose Y; Ishida Y; Hayashida K; Kawano S; Fukuoka S; Uehara T; Nishimura T Kaku Igaku; 1996 Jan; 33(1):19-25. PubMed ID: 8819711 [TBL] [Abstract][Full Text] [Related]
17. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy. J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617 [No Abstract] [Full Text] [Related]
18. The value of 99mTc-MIBI myocardial perfusion imaging in differentiation of heart failure conditioned by global left ventricular systolic impairment. Ragaisyte N; Kavoliūniene A; Vaicekavicius E; Navickas R; Kulakiene I; Vencloviene J; Laukaitiene J; Janenaite J; Janavicius A Medicina (Kaunas); 2009; 45(4):262-8. PubMed ID: 19423956 [TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of magnetic resonance myocardial delayed enhancement. Zhang ZH; Miao Q; Lin SB; Zhang SY; Li DJ; Chen LB; Zhang H; Wang YN; Zhou L; Kong LY; Feng F; You H; Sun HY; Zhao WM; Zhang LR; Jin ZY Chin Med Sci J; 2006 Dec; 21(4):245-51. PubMed ID: 17249200 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Danias PG; Papaioannou GI; Ahlberg AW; O'Sullivan DM; Mann A; Boden WE; Heller GV Am J Cardiol; 2004 Jul; 94(1):14-9. PubMed ID: 15219501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]